Braslyn Ltd.

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Braslyn Ltd. reported 2 stock positions worth $2.3 million. Its top holding was Inseego (INSG) at 90.9% of the portfolio, followed by Tango Therapeutics (TNGX, 9.1%). Compared with Q4 2023, it sold out of 1. The biggest sale was an exit from Mirati Therapeutics (MRTX).

Most Recent 13F
Q4 2024
Location
NEW PROVIDENCE, C5
CIK
0001642355
Portfolio Value
$2.3M (Q1 2024)
SEC Filing
0000895345-24-000184 ↗ filed May 15, 2024

Holdings Value

0$5.0M$10.0M$15.0M Q1 2024: $2.3M $2.3M Q1 2024 Q2 2024: $8.3M Q2 2024 Q3 2024: $12.6M Q3 2024 Q4 2024: $7.8M Q4 2024

Holdings 2 stocks · $2.3M
INSG Inseego Corp. 90.88% 761,483 $2.1M No change
TNGX Tango Therapeutics Inc. 9.12% 26,961 $214K No change

Portfolio Sells Q4 2023 → Q1 2024
MRTX Mirati Therapeutics Inc. Sold out 0.00% −98.96

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2024 1$7.8MINSG
Q3 2024 2$12.6MINSG, TNGX
Q2 2024 2$8.3MINSG, TNGX
Q1 2024 2$2.3MINSG, TNGX